[New data on the physiopathology and therapy of bronchial constriction].
D000262:Adenylyl Cyclases / Q000378:metabolism; D000316:Adrenergic alpha-Agonists / Q000627:therapeutic use; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D001986:Bronchial Spasm / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D002118:Calcium / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003533:Cyproheptadine / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D008784:Methysergide / Q000627:therapeutic use; D009130:Muscle, Smooth / Q000503:physiopathology; D010277:Parasympathomimetics / Q000627:therapeutic use; D013806:Theophylline / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D006634:Histamine H1 Antagonists; D010277:Parasympathomimetics; D003533:Cyproheptadine; D013806:Theophylline; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D002118:Calcium; D008784:Methysergide
Neue Erkenntnisse über Pathophysiologie und Therapie der Bronchokonstriktion